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Hot melt extrusion (HME) uses a rotating screw and elevated temperature to pump dry, raw materials through a die and into a product of uniform shape. It
is currently one of the most widely used processing techniques within the plastics industry and has drawn the attention of the pharmaceutical industry.
Several research groups have already demonstrated the possibility of HME in the processing of API’s e.g. nifedipine, theophyline, into various
pharmaceutical forms including tablets, granulates and implants [1].
Peptides make up a promising class of new therapeutics. Recently, new manufacturing and delivery techniques, combined with intensified research and
development programs, resulted in the approval of an anti-HIV peptide drug Fuzeon® and an estimated total of 200 peptides in various clinical stages [2].
Depending on the therapeutic application, processing of certain peptides e.g. anti-cancer peptides, into implants with appropriate release rates, would be
beneficial for patient compliance and therapeutic effect. Due the to high temperatures reached, HME of peptides is surrounded by skepticism. In order to
evaluate the HME processing possibilities of peptides, a number of selected peptides, present in a casein hydrolysate sample, were subjected to dry heat
stress stability tests.
Casein hydrolysate characterization: HPLC-UV/ESI Iontrap MS, peptide C18 fused-core column (75 mm × 3.0 mm, 2.7 µm; HALO; Achrom), linear gradient
(MFA: 0.1 % (m/V) FA in H2O; MFB: 0.1 % (m/V) FA in acetonitrile) T0 min.: 95/5 (V/V) A/B; T40 min.: 71/29 A/B; 0.6 mL/min., 195 nm.
Experimental design (duplicate): 100 °C – 140 °C – 180 °C
1 min. – 3 min. – 5 min.
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RESULTS and DISCUSSION 
Hot-melt extrusion related dry heat stress stability study performed with a model peptide mixture set, originating from casein hydrolysate, showed peptide 
extrusion potential up toward 5 minutes at 140 °C and 3 minutes at 180 °C. However, significant degradation, ranging from 10 % to 40 %, was seen during 
5 minutes incubation at 180 °C.
CONCLUSIONS
REFERENCES
1. Model peptide mixture characterization (HPLC-ESI Iontrap MS)
2. Dry heat stress stability tests (HPLC-UV)
Peak information Relative amount 100 °C (%)(1,2) Relative amount 140 °C (%)(1,2) Relative amount 180 °C (%)(1,2)
RT (min.) AA sequence 1 min. 3 min. 5 min. 1 min. 3 min. 5 min. 1 min. 3 min.(3) 5 min.(3)
9.08 NKKIE 102.24 100.73 96.83 97.00 95.52 94.23 88.60 94.37 85.23
10.17 YPVEP 105.06 101.99 102.29 98.55 101.41 99.67 94.63 97.51 78.53






104.04 99.58 98.23 99.56 100.36 99.89 94.57 101.44 75.59
17.40 DIPNPI 109.59 105.16 102.50 105.86 105.42 98.03 96.49 101.15 94.26
17.70 SDIPNPI 110.48 109.87 101.30 103.74 98.39 95.01 97.18 93.45 75.04
19.19 RGPFPI 110.03 107.78 101.35 100.52 107.09 105.84 101.24 92.95 71.43
20.88 PFPGPIPNAPFPEV 106.31 104.34 100.85 103.42 102.31 103.03 98.62 98.35 70.52
24.78 YPFPGPIPN 101.90 99.24 102.35 96.53 98.82 98.53 100.65 93.76 62.77
26.16 VVPPFLQPE 107.89 104.82 102.38 100.83 102.96 101.72 98.24 98.71 83.32
27.00 VYPFPGPIPN 104.84 99.33 99.21 95.93 100.23 97.89 95.06 95.54 63.96
28.73 TDAPSFSDIPNPI 105.49 102.37 102.39 99.35 101.15 100.36 97.38 99.03 76.90
29.83 VYPFPGPI 108.17 103.55 101.16 98.83 99.18 96.42 93.72 91.24 89.69
(1) Calculated using formula: ((∑peak area stressed) / (∑peak area unstressed))
(2) Peptide abundance outside [90-110 %] interval relative to unstressed sample are considered significant and indicated in bold







































# Retention time (min.) Observed [MH]+ Amino acid sequence Origin
1 9.66 631.26 NKKIE β-casein
2 11.21 604.15 YPVEP β-casein











6 18.53 668.10 DIPNPI αS1-casein
7 18.89 755.18 SDIPNPI αS1-casein






10 26.31 1001.28 YPFPGPIPN β-casein
11 27.69 1025.33 VVPPFLQPE β-casein
12 28.46 1100.36 VYPFPGPIPN β-casein
13 30.11 1373.33 TDAPSFSDIPNPI αS1-casein
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